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 Introductions: Radical cystectomy with bilateral pelvic lymphadenectomy 
is a primary intervention for muscle invasive or refractory, high grade Ta, 
T1, Tis bladder cancer. Owing to its major undertaking, patient succumbs 
to infection and various morbidities. This study was to assess the 
perioperative outcomes and complications of radical cystectomy.  
 
Methods: This retrospective study analyzed the perioperative outcome 
(early mortality within 30 days, length of stay, requirement of blood 
transfusion) of radical cystectomy in patients with bladder cancer during 
four years at Patan Hospital, Patan Academy of Health Sciences, Lalitpur, 
Nepal. Ethical approval was obtained. Study variables included patient’s 
demographics, presenting symptoms, tumor types and configuration, 
need for blood transfusion, length of surgery, pathological stages, types of 
urinary diversions, hospital stay, early (<30 days) and late (31-90 days) 
morbidity and mortality. 
 
Results: Total 32 patients underwent radical cystectomy. Data analysed on 
18 patients, mean age was 66.7 years and painless hematuria 17 (94.4%). 
All were transitional cell carcinoma, high grade lesion in 17 (94.4%). 
Overall 6 (33.3%) patients developed early postoperative complications, 
paralytic ileus and prolong lymph drainage in 5 (27.8%), wound dehiscence 
in 4 (22.2%) and ureteric catheter dislodgement in two. There were 2 
(11.1% of 18) mortalities (the mortality audit showed total 5 (15.6%) out 
of 32 radical cystectomy during the study period. 
 
Conclusions: Perioperative complications occurred in 1/3rd following 
radical cystectomy for muscle invasive bladder, more complications in 
those with preoperative associated co-morbidities. 
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Bladder cancer is the sixth most common 
cancer worldwide.1 It is 5th common cancer in 
male in Nepal.2 Radical cystectomy, pelvic 
lymph node dissection and urinary diversion is 
the gold standard treatment for muscle 
invasive bladder cancer (MIBC) and selected 
high-risk non-MIBC.3 Despite refinements in 
surgical techniques and anesthesia, 
perioperative morbidity remains a challenge as 
patients are relatively elderly with multiple 
comorbidities.4 Left alone or insufficiently 
treated, MIBC has high morbidity due to local 
and systemic progression, repeated 
hospitalizations and death.  
 
American Society of Anaesthesiology (ASA) 
score, carcinoma in-situ and tumor stages are 
some of the predictors for increased rate and 
severity of early complications after radical 
cystectomy.5 Open radical cystectomy without 
selecting favorable patient group has accepted 
morbidity, mortality, median length of stay of 
less than a week and an estimated blood loss 
of approximately 2-units.6 Despite 
technological advances perioperative 
morbidity has remained stable at 11 to 68%.7 
In this 4-years single center review we aim to 
analyse the perioperative outcome of radical 
cystectomy for MIBC in local scenario, which 
will provide information that may serve the 
basis for future interventions to reduce the 
morbidities and complications of radical 





This study includes patients who had radical 
cystectomy for MIBC during 4 years period 
from March 2015 to February 2019 at Patan 
Hospital, Patan Academy of Health Sciences 
(PAHS), Nepal. Ethical approval was obtained 
from institutional review committee, IRC-
PAHS. 
 
In-patient identification numbers of patients 
who had radical cystectomy for bladder cancer 
were searched from operation room register. 
The files were retrieved from the hospital 
record section for data analysis. Variables 
analysed were patient demographics (sex, 
age), presenting symptoms (painless 
hematuria, irritative bladder symptoms and 
history of smoking), ASA grade with known 
concomitant co-morbidities (hypertension, 
diabetes, COPD, heart disease), tumor types 
configuration and pathological stage, length of 
surgery, types of urinary diversions, estimated 
blood loss and need for blood transfusion, 
post-operative complications (paralytic ileus, 
lymphorrhea, respiratory problems, small 
bowel obstruction, anastomotic leak), 
adjunctive procedures to control 
complications, days of hospital stay and early 
within 30 days and late 31 to 90 days morbidity 
mortality. 
 
Inoperable (surgeon’s decision during intra-
operative period), those treated with modality 
other than radical cystectomy, incomplete 
data or patients case file not available from 
hospital record section were excluded from 
analysis. The mortality was calculated both in 
patients whose record files were available and 
also the overall mortality out of total radical 
cystectomy during the study period from 
monthly morbidity- mortality audit system in 
the surgery department. 
 




• Intraoperative hemorrhage: hematocrit 
fall calculated by the difference in value 
soon after surgery and preoperative value. 
• Sepsis: postoperative fever (temperature 
more than 38 or less than 36oC), pulse 
more than 100/minute, respiratory rate 
more than 20/minute, total leukocyte 
count more than 12000/mm3 or less than 
4000/mm3.  
• Prolong length of stay: hospital stay more 
that 2-weeks after surgery.  
• Prolong lymphorrhea: drainage of lymph 
from abdominal drain for more than two 
weeks. 
• Paralytic ileus: postoperative vomiting 
associated with abdominal distension until 
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without signs of small bowel obstruction 
and cessation of oral intake or need of 
nasogastric decompression.   
• Acute respiratory distress: severe 
respiratory insufficiency requiring 
unplanned intubation and assisted 
respiration. 
• Wound dehiscence: wound breakdown 
with disruption of fascial suture requiring 
surgical repair. 
• Pelvic lymph node dissection: standard 
template of the anatomic boundaries 
includes genitofemoral nerves laterally, 
the internal iliac artery medially, Cooper 
ligament inferiorly, and the point at which 
the ureter crosses the common iliac artery 
superiorly. Lymph nodes within the 
boundaries of internal iliac, external iliac, 
obturator, and presacral are removed. 
• Early perioperative complications: adverse 
event within 30 days of surgery. 
• Perioperative mortality: death from any 
cause within 30 days of surgery.  
• Late complications: complication noted 
more than 31-90 days after surgery 
• Definitions of concomitant comorbidities: 
1. Hypertension: stage-1 hypertension or 
above (ASA classification)9 with at 
least one antihypertensive drug for 
more than 3 months. 
2. Diabetes: on treatment with oral anti-
hyperglycemic agent or insulin. 
3. Coronary heart disease: with coronary 
stents or history of coronary artery 
bypass or myocardial infarction, or 
two episodes of angina pectoris with 
long-term medication with at least one 
specific drug (nitroglycerin, beta 
blockers, calcium channel blockers or 
angiotensin converting enzyme (ACE) 
inhibitors). 
4. Chronic obstructive pulmonary 
disease (COPD): confirmed by 
spirometry, on long-term medication 
with bronchodilators and/ or 
corticosteroids. 
 
At our center, radical cystectomy is performed 
with curative intent by standard technique 
under general anesthesia together with 
placement of epidural catheter, central line, 
routine prophylactic antibiotics (inj. durataz & 
inj. metronidazole) and Foley’s 
catheterization. Patient is put in supine 
position bed flexed 15 degrees at the level of 
anterior superior iliac spine to facilitate access 
to the deeper abdominal structure through 
lower midline incision. Surgical dissection 
includes, in male- cystoprostatectomy 
including prostate, seminal vesicles; in female- 
cystectomy together with removal of uterus, 
adnexa, anterior vaginal wall and urethra. 
Pelvic lymphadenectomy is carried out as per 
standard template dissection of lymph nodes. 
 
For ileal conduit, uretero-enteric mucosa to 
mucosa anastomosis in single layer was 
performed in continuous pattern with 
polyglactin 5-0 (Bricker’s type in 16 patients 
and Wallace type in 2 patients) over 6 Fr 
ureteric catheter, followed by end to end ileo-
ileal anastomosis in single layer extra-mucosal 
interrupted fashion with polyglactin 3-0 
suture. The distal end of ileal conduit is 
brought out as stoma at right lower abdomen.   
 
For orthotopic neobladder, Studer’s pouch was 
considered. To construct the reservoir, a 45-50 
cm ileal segment was isolated about 20-25 cm 
proximal to the ileocecal valve. About 30-35 
cm of the distal ileal segment is then de-
tubularized on the antimesenteric border, 
leaving the proximal 15 cm intact for later 
implantation of the ureters. To construct the 
reservoir, the adjacent de-tubularized limbs 
are folded into a U shape, and the back wall 
were over-sewn. The bottom of the U was 
folded over between the two ends of the U, 
resulting in a roughly spherical shape reservoir 
consisting of four cross-folded ileal segments.9 
The ureters were next anastomosed to the 
afferent tubular segment in end-to-side 
refluxing fashion. Finally, the reservoir was 
anastomosed to native urethra, 
 
Our routine protocol for symptomatic 
management of complications include high 
flow oxygen, antibiotics and chest 
physiotherapy in incentive care unit for 
pneumonia and acute respiratory distress;  
intravenous fluids, nil per oral and prokinetics 
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supplementation and drainage for 
lymphorrhea; revision laparotomy with 
tension suturing for abdominal wound 
dehiscence; dressings and broad spectrum  
antibiotics for surgical site infection (SSI); 
laparotomy for small bowel obstruction not 
relieved by conservative management. 
 
In order to diagnose possible urinary leak from 
abdominal drain, we opt to measure drain fluid 
to serum creatinine ratio. A ratio of more than 
10 is considered urinary leak. Ureteric 
catheters are routinely removed at 1-week of 
surgery. Followup is done routinely in 
outpatient surgical referral clinic by consultant 




Out of total of 32 radical cystectomy 
performed during the four years study period, 
data on 18 patients were analysed after 
excluding 14 with incomplete data or whose 
files were not available. Out of 18 patients, 17 
(94.4%) were males and 1 (5.6%) was female. 
The mean age was 66.67 years. Painless 
hematuria was present in 17 (94.4%), irritative 
symptoms in 11 (61.1%) and history of smoking 
in 13 (72.2%) of the patients. Thirteen (72.2%) 
of the patients were in ASA grade-2 with 1/4th 
having known concomitant co-morbidities of 
hypertension, followed by diabetes and COPD, 
Table 1. 
 
Table 1. Prevalence of the most frequent known concomitant co-morbidities in bladder cancer patients who 
had radical cystectomy (N=18) 
 
Comorbidities N %* 
Hypertension  4 22.2 
Diabetes 3 16.6 
COPD 3 16.6 
Heart disease 1 5.5 
Anemia 9 50.0 
*total % adds up to more than 100 because of more than one co-morbidities in one patient 
 
Table 2. Local tumor (T) stages after final histopathology examination of radical cystectomy for bladder cancer 
(N=18) 
 














Table 3. Early complications within 30 days after radical cystectomy (N=18) for bladder cancer 
 
 
Perioperative complications (<30 days) N % 
Medical   
Pneumonia 4 22.2 
Acute respiratory distress 3 16.6 
Atrial fibrillation 1 5.5 
Cardio respiratory arrest 1 5.5 
Surgical    
Paralytic ileus 5 27.7 
Prolong lymph drainage (lymphorrhea) 5 27.7 
Wound dehiscence 4 22.2 
Surgical site infection (SSI) 3 16.6 
Anastomotic dehiscence 2 11.1 
Ureteric catheter dislodgement 2 11.1 
Massive intraoperative bleeding 1 11.1 
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Table 4. Late postoperative complications 31-90 days after radical cystectomy (N=18) for bladder cancer 
 
 
Late postoperative complications (>30 days) N % 
Peristomal irritation 2 11.1 
Incisional hernia 1 5.5 
Uretero-enteric anastomosis stricture 1 5.5 
Enteric fistula 1 5.5 
Stress incontinence 1 5.5 
All patients had transitional cell carcinoma, 17 
(94.4%) high grade lesions. Five (27.7%) 
wereT1 lesions, 11 (61.1%) T2 and one each T3 
and T4. Four (22.2%) patients had positive 
lymph nodes. Multiple lesions were present in 
12 (66.7%), papillary 7 (38.9%) followed by 
solid tumor in 6 (33.3%). One patient had 
urethral invasion seen on preoperative 
transurethral (TUR) specimen. Primary tumors 
accounted for 11 (61.1%) of the cases, while 
rests were recurrent. 
 
Neoadjuvant radiation therapy was given to 
two patients and chemotherapy in three. Ten 
(55.6%) patients received Mitomycin C and 
one received Bacillus Calmette-Guerin (BCG) 
intravesical therapy after initial transurethral 
resection of bladder tumor (TURBT), refractory 
to BCG. 
 
Mean operative time was 402.4±60.2 minutes, 
postoperative hematocrit drop 8.28% and 
blood transfusion in 14 (78%).  
 
Urinary diversion was performed with Ileal 
conduits in 17 (94.4%) and Studer’s pouch 
(ileal neobladder) in 1 (5.55%). One patient 
with urethral invasion underwent 
urethrectomy. Histologically 11 (61.1%) were 
T2 lesion, Table 2. In four patients with T2b 
stage, lymph nodes were histologically 
positive. 
 
Hospital stay was 19.2±5.8 days (median 16). 
Longer hospital stay was seen in those who had 
complications 26.1±10.3 days (median 21). 
 
Early complications of paralytic ileus, 
lymphorrhea occurred in 1/4th of patients 
followed by wound dehiscence, and 
pneumonia in 5 (27.7%), Table 3.   
 
Ureteric catheter dislodgement occurred in 2 
(11.1%) of the patients on the first 
postoperative day, both during replacement of 
urostomy bag and no significant urinary leak 
was observed in the abdominal drain following 
the dislodgement, as drain to urinary 
creatinine ratio was below 10:1. 
  
There were 2 (11.1%) postoperative 
mortalities among 18 cases analysed, however 
there were total 5 (15.6%) mortalities out of 32 
cases as per morbidity-mortality audit record 
in the department.  
 
The same morbidity-mortality reporting 
system also helped us to find out the exact 
cause of death in all the cases. Two were 
secondary to bowel complication due to 
anastomotic dehiscence, one each secondary 
to respiratory complication of pneumonia and 
intraoperative bleeding and cardiorespiratory 
arrest respectively. Arrest occurred during 
extubation phase of anaesthesia, however 





Overall early postoperative morbidities in our 
study was seen in 6 (33.3%), comparable to 
other larger studies reporting early 
complication of 38.6%8 in 452 and 33%10 in 70 
patients. However, there is currently 
standardized way to define complications or 
compare complication rates within the 
urological literature and radical cystectomy 
itself is considered to have major impact to 
these patients during lengthy surgical 
procedure.10 Patients with MIBC are usually 
elderly. The average age of patients in our 
series was 66.7 years (range 53-77) and 13 
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associated comorbidities. While improved 
patient selection and early detection could 
potentially reduce these rates, it is unlikely 
that significant reductions will be realized in 
the foreseeable future with similar operative 
due to old age of patients and requiring 
extensive surgical dissection and 
reconstruction. 
 
Intraoperative and or postoperative blood 
transfusion was required in 14 (78%) of our 
patients, while others series report lower 
transfusion rate ranging between 39 and 
65%.11,12 In the study of 553 patients of radical 
cystectomy, 210 (38%) received blood 
transfusion either during surgery or in early 
postoperative period.13 Preoperative anemia, 
high estimated blood loss, older age, non-
organ confined disease, ileal conduit urinary 
diversion are the potential factors to dictate 
blood transfusion.13 The relatively high 
transfusion rate in our series may be due to 
these well-known factors, plus preoperative 
anemia in 50% of the patients; ileal conduit 
urinary diversion in 94.4% and postoperative 
hematocrit drop of 8.3%. Besides these, 
intraoperative transfusion in our category of 
patients was to maintain bodily homeostasis 
and avoid eventual anastomotic break down 
due to intraoperative hypotension (iatrogenic) 
or hypovolemia.  
 
The median hospital stay in our series was 16 
days, longer than 6 days in a larger series of 
553 patients.13 The relatively prolonged 
hospital stay in our study may be due to the 
complications of prolonged ileus; anastomotic 
leak and wound dehiscence. Other possible 
reason could be our patients do not prefer to 
get discharged early owing to generally poor 
socioeconomic status of our population, poor 
transport facilities and non-existent 
community nurses for postoperative care. 
However, could not specifically looked into 
these factors owing to retrospective analysis.  
The average hospital stay after radical 
cystectomy in the literature ranges between 7 
and 34 days.10 Much shorter hospital stays is 
seen in the US as compared to European 
countries.14 
 
One of the most common postoperative 
complications after radical cystectomy with 
urinary diversion is paralytic ileus. The ileus 
rate in our series was 27.7% compared to 
reports of as low as 8.6% in the literature.8Ileus 
result from the stress of surgery, which causes 
generalized sympathetic stimulation and could 
initiate a spinal reflex arc that impairs 
gastrointestinal motility. Despite early 
ambulation, prokinetics, and early feeding, we 
had increased rate of ileus. It probably was due 
to opiates analgesics and neurogenic 
comorbidity like diabetes and hypertension in 
some of our patients. 
 
Higher ASA-grade, advanced age and 
comorbidities are possible risk factors for 
complications. Among 18 patients in our 
series, 13 (72.2%) were in ASA grade-2 with 
various concomitant co-morbidities of 
hypertension seen in 4 (22.2%), diabetes in 3 
(16.6%), COPD 3 (16.6%), and heart disease 1 
(5.5%). In literature the reported independent 
risk factors for postoperative morbidities are 
age and ASA grade >3.15 Similarly, age and 
cardiac disease are also independent risk 
factor for postoperative complication.16 In a 
prospective study, patients of ASA 3 or more 
were found susceptible to complications.17 
 
There were altogether 5 (15.6%) mortality in 
our study when all the 32 cases were taken into 
consideration. Mortality figures were retrieved 
from our monthly departmental audit data. 
Reported mortality rates after radical 
cystectomy range between 0 and 9.5%, 
depending on the size of the series and the 
defined postoperative period.18,19 A 12.7%, 90-
day overall mortality was reported in 2011 re-
affirming that radical cystectomy is safe in high 
risk elderly patients.20 
 
We have certain limitations in our study like 
the limitations inherent to retrospective 
analysis, small sample size and relatively 
underutilization of neoadjuvant therapy in our 
patients compared to current 
recommendations that may influence 
outcome. Prime reason to avoid neoadjuvant 
chemotherapy in our patients was anxiety and 
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cancer surgery. However, our data represents 
acceptable overall outcome of radical 
cystectomy for MIBC performed at low volume 





Our study reflects the outcome of radical 
cystectomy and pelvic lymphadectomy for 
muscle invasive bladder cancer had acceptable 
perioperative morbidities and mortality, in 
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